Search Results - "van de Kerkhof, D."

Determination of dabigatran, rivaroxaban and apixaban by ultra‐performance liquid chromatography – tandem mass spectrometry (UPLC‐MS/MS) and coagulation assays for therapy monitoring of novel direct oral anticoagulants by Schmitz, E. M. H., Boonen, K., den Heuvel, D. J. A., Dongen, J. L. J., Schellings, M. W. M., Emmen, J. M. A., Graaf, F., Brunsveld, L., Kerkhof, D.

“…Background Three novel direct oral anticoagulants (DOACs) have recently been registered by the Food and Drug Administration and European Medicines Agency…”
Get full text

Harmonizing light transmission aggregometry in the Netherlands by implementation of the SSC-ISTH guideline by Munnix, I.C.A., Van Oerle, R., Verhezen, P., Kuijper, P., Hackeng, C.M., Hopman-Kerkhoff, H.I.J., Hudig, F., Van De Kerkhof, D., Leyte, A., De Maat, M.P.M., Oude Elferink, R.F.M., Ruinemans-Koerts, J., Schoorl, M., Slomp, J., Soons, H., Stroobants, A., Van Wijk, E., Henskens, Y.M.C.

“…Light transmission aggregometry (LTA) is considered the gold standard method for evaluation of platelet function. However, there are a lot of variation in…”
Get full text

Liver injury in long‐term methotrexate treatment in psoriasis is relatively infrequent by BERENDS, M. A. M., SNOEK, J., DE JONG, E. M. G. J., VAN DE KERKHOF, P. C. M., VAN OIJEN, M. G. H., VAN KRIEKEN, J. H., DRENTH, J. P. H.

“…Summary Background Methotrexate‐induced liver damage in psoriasis has led to dermatologic guidelines that stipulate monitoring of liver injury by means of…”
Get full text

Evaluation of Testosterone/Epitestosterone Ratio Influential Factors as Determined in Doping Analysis by van de Kerkhof, D.H., de Boer, D., Thijssen, J.H.H., Maes, R.A.A.

“…The ratio of the concentration of testosterone glucuronide to the concentration of epitestosterone glucuronide (T/E ratio) as determined in urine is the most…”
Get full text

Artifact formation due to ethyl thio-incorporation into silylated steroid structures as determined in doping analysis by van de Kerkhof, D.H, van Ooijen, R.D, de Boer, D, Fokkens, R.H, Nibbering, N.M.M, Zwikker, J.W, Thijssen, J.H.H, Maes, R.A.A

“…Trimethylsilylation of target substances in a mixture of N-methyl- N-trimethylsilyltrifluoroacetamide (MSTFA), ammonium iodide and ethanethiol is frequently…”
Get full text

A value proposition for trough level-based anti-TNFα drug dosing by Scharnhorst, V., Schmitz, E.M.H., van de Kerkhof, D., Derijks, L.J.J., Broeren, M.A.C.

“…Treatment of inflammatory bowel diseases and rheumatic disorders with anti-tumor necrosis factor alpha (TNFα) drugs is expensive, while a significant…”
Get full text

Determination of dabigatran and rivaroxaban by ultra-performance liquid chromatography-tandem mass spectrometry and coagulation assays after major orthopaedic surgery by Schellings, M.W.M, Boonen, K, Schmitz, E.M.H, Jonkers, F, van den Heuvel, D.J, Besselaar, A, Hendriks, J.G.E, van de Kerkhof, D

“…Abstract Major orthopaedic surgery is associated with an increased risk of venous thromboembolism. Direct oral anticoagulants (DOACs) are recommended as…”
Get full text

The hereditary palmoplantar keratoses: an updated review and classification by Lucker, G P, Van de Kerkhof, P C, Steijlen, P M

“…The palmoplantar keratoses (PPKs) comprise a heterogeneous group of disorders of keratinization, which can be subdivided into hereditary and acquired forms…”
Get more information

Left atrial thrombus under dabigatran in a patient with nonvalvular atrial fibrillation by Janssen, A M, van de Kerkhof, D, Szabó, B, Durian, M F, van der Voort, P H

“…Dabigatran is a new direct competitive inhibitor of thrombin and is equally effective and safe as warfarin in the prevention of thromboembolism in patients…”
Get full text

Charcot-Leyden crystals in acute myeloid leukemia by van de Kerkhof, D., Scharnhorst, V., Huysentruyt, C. J. R., Brands-Nijenhuis, A. V. M., Ermens, A. A. M.

Get full text

Two novel mutations in the prothrombin gene identified in a patient with compound heterozygous type 1/2 prothrombin deficiency by Kuijper, P. H. M., Schellings, M. W. M., van de Kerkhof, D., Nicolaes, G. A. F., Reitsma, P., Halbertsma, F., Dors, N.

Get full text

Transfusion reaction caused by anti-Vr, the first case reported by Boonen, K., van der Stokker, A., Folman, C., van de Kerkhof, D.

Get full text

Reducing the immediate availability of red blood cells in cardiac surgery, a single-centre experience by Haanschoten, M. C., van Straten, A. H. M., Verstappen, F., van de Kerkhof, D., van Zundert, A. A. J., Soliman Hamad, M. A.

“…Background In our institution, we have redefined our criteria for direct availability of red blood cell (RBC) units in the operation room. In this study, we…”
Get full text

Early double stent thrombosis associated with clopidogrel hyporesponsivenesss by Rademakers, L. M., Dewilde, W., van de Kerkhof, D.

“…A 57-year-old male patient without cardiovascular history suffered an acute myocardial infarction and underwent drug-eluting stent implantation in the left…”
Get full text

Multiple squamous cell carcinomas in a psoriatic patient following high–dose photochemotherapy and cyclosporin treatment: response to long–term acitretin maintenance by KERKHOF, P.C.M., ROOIJ, M.J.M.

“…Summary Cumulative toxicity is a well known limitation of antipsoriatic treatments. In particular, the induction of multiple squamous cell carcinomas following…”
Get full text

Methotrexate revisited: effects of long-term treatment in psoriasis by Van Dooren-Greebe, R J, Kuijpers, A L, Mulder, J, De Boo, T, Van de Kerkhof, P C

“…In the past 22 years, 113 patients with severe psoriasis have been treated with low-dose methotrexate (MTX) in our department. The maximum weekly dosage was 15…”
Get more information

Blood group genotyping in a multitrauma patient: a case report by Curvers, J, Scharnhorst, V, de Haas, M, Warnier-Wandel, L, van de Kerkhof, D

“…Currently DNA-based analysis of blood groups is mainly used to improve transfusion safety by reducing alloantibody formation in multiply transfused patients…”
Get more information

Tacalcitol ointment in the treatment of psoriasis vulgaris:a multicentre, placebo-controlled, double-blind study on efficacy and safety by VAN DE KERKHOF, P.C.M., WERFEL, T., HAUSTENIN, U.F., LUGER, T., CZARNETZKI, B.M., NIEMANN, R., PLÄNITZ-STENZEL, V.

“…Summary Tacalcitol is a vitamin D analogue which has been developed for the therapy of psoriasis vulgaris. The treatment with a twice daily application of…”
Get full text

Response of the clinically uninvolved skin of psoriatic patients to standardized injury by van de Kerkhof, P C, van Rennes, H, de Grood, R M, de Jongh, G J, Bauer, F W, Mier, P D

“…Test sites on healthy controls and on the clinically uninvolved skin of psoriatic patients were stripped with tape, and eight variables were quantified at…”
Get more information

Topical treatment of pityriasis rubra pilaris with calcipotriol by Van de Kerkhof, P C, Steijlen, P M

“…From a clinical, histological and therapeutic point of view, psoriasis and pityriasis rubra pilaris share important characteristics. Recently, calcipotriol has…”
Get more information